FI80044B - Fosforsyravinylbenzylestrar, deras framstaellning och anvaendning. - Google Patents

Fosforsyravinylbenzylestrar, deras framstaellning och anvaendning. Download PDF

Info

Publication number
FI80044B
FI80044B FI853623A FI853623A FI80044B FI 80044 B FI80044 B FI 80044B FI 853623 A FI853623 A FI 853623A FI 853623 A FI853623 A FI 853623A FI 80044 B FI80044 B FI 80044B
Authority
FI
Finland
Prior art keywords
group
phosphoric acid
formula
tetrahydro
naphthyl
Prior art date
Application number
FI853623A
Other languages
English (en)
Finnish (fi)
Other versions
FI80044C (sv
FI853623A0 (fi
FI853623L (fi
Inventor
Fritz-Frieder Frickel
Axel Nuerrenbach
Hans-Heiner Wuest
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of FI853623A0 publication Critical patent/FI853623A0/fi
Publication of FI853623L publication Critical patent/FI853623L/fi
Application granted granted Critical
Publication of FI80044B publication Critical patent/FI80044B/fi
Publication of FI80044C publication Critical patent/FI80044C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/094—Esters of phosphoric acids with arylalkanols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/24—Esteramides
    • C07F9/2404—Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2429—Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic of arylalkanols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65742—Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring

Claims (2)

1. Förfarande för framställning av säsom läkemedel användbara fosforsyravinylbensylestrar med formeln I 5 R7 T”9 10. jr 1 r1r2 l R4 väri A är en eventuellt med C1_t-alkylgrupper substituerad me-15 tylen- eller etylengrupp, R1 och R2 betecknar en väteatom eller metylgrupp, R3 är en väteatom eller metyl-, hydroxi- eller Cx_6-alk-oxigrupp, R4 och R5 betecknar en väteatom, C3 _ 4-alkyl- eller metoxi-20 grupp eller halogenatom, R6 är en väteatom, Cx _ 6-alkyl- eller C3 _ 6-cykloalkylgrupp, R7 är en väteatom eller Cx_4-alkylgrupp, och R8 och R9 betecknar en grupp -OR1 0 eller -NR11R12, varvid R1 0 är en väteatom eller Cj.8-alkyl-, fenyl- eller bensyl-25 grupp, R11 och R12 betecknar en väteatom, Cx. 6-alkylgrupp eller tillsammans med kväveatomen, vid vilken de är bundna, en pyrrolidino-, piperidino- eller morfolinogrupp, och varvid i varje enskilt fall tvä av grupperna R10 , R11 30 och/eller R12 kan ocksä tillsammans beteckna en etylen-eller propylengrupp, samt deras fysiologiskt godtagbara salter, känne-t e c k n a t därav, att a) en alkohol med formeln 11 18 80044 R7 K3 R6 yOQj oh r1^V^h5 R R 10 väri A och R1 - R7 betecknar samma som ovan, omsätts med en fosforylationsreagens med formeln III R8 o=p-r9 IIX
15 X väri R8 och R9 betecknar samma som ovan och X är en halo-genatom, en imidazol-, N,N'-dicyklohexylisourea-, triklor-acetimidat-, p-toluensulfonyloxi-, p-nitrofenyloxi- eller 20 mesityloxigrupp eller en grupp -0-P(0)ReR9, eller b) en alkohol med formeln II omsätts under oxide-rande förhällanden med en fosforylationsreagens med formeln V R8 25 1 0=P-R9 V H väri R8 och R9 betecknar samma som ovan, 30 och de s& erhällna föreningarna eventuellt omvand- las till deras fysiologiskt godtagbara salter.
2. Förfarande enligt patentkravet 1, känne-t e c k n a t därav, att man framställer föreningar med formeln I säsom definierats i patentkravet 1, i vilka 35 II 19 80044 A är en eventuellt med en metylgrupp substituerad etylen-grupp, R3, R4 och R5 betecknar väteatomer, R6 är en väteatom eller metylgrupp, och 5 R9 är en hydroxi- eller C1_4-alkoxlgrupp.
FI853623A 1984-09-22 1985-09-20 Förfarande för framställning av fosforsyravinylbensylestrar användbara som läkemedel FI80044C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3434945 1984-09-22
DE3434945 1984-09-22
DE19843438386 DE3438386A1 (de) 1984-09-22 1984-10-19 Phosphorsaeurevinylbenzylester, ihre herstellung und verwendung
DE3438386 1984-10-19

Publications (4)

Publication Number Publication Date
FI853623A0 FI853623A0 (fi) 1985-09-20
FI853623L FI853623L (fi) 1986-03-23
FI80044B true FI80044B (fi) 1989-12-29
FI80044C FI80044C (sv) 1990-04-10

Family

ID=25825026

Family Applications (1)

Application Number Title Priority Date Filing Date
FI853623A FI80044C (sv) 1984-09-22 1985-09-20 Förfarande för framställning av fosforsyravinylbensylestrar användbara som läkemedel

Country Status (9)

Country Link
US (1) US4659701A (sv)
EP (1) EP0176050B1 (sv)
AU (1) AU573389B2 (sv)
CA (1) CA1339138C (sv)
DE (2) DE3438386A1 (sv)
FI (1) FI80044C (sv)
HU (1) HU193818B (sv)
IL (1) IL76455A (sv)
NO (1) NO853697L (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177241A (en) * 1987-12-31 1993-01-05 Bronstein Irena Y Synthesis of 1,2-dioxetanes and intermediates therefor
EP0303713B2 (en) * 1987-02-23 1997-07-30 Shiseido Company Limited Percutaneous absorption promoter and dermatologic preparation for external use
US5057502A (en) * 1987-06-02 1991-10-15 Walsh William E Composition and topical and systemic treatments of conditions caused by heavy, oily or greasy secretions
DE3726806A1 (de) * 1987-08-12 1989-02-23 Basf Ag Arylphosphorderivate, ihre herstellung und verwendung
US6670344B2 (en) * 2000-09-14 2003-12-30 Bristol-Myers Squibb Company Combretastatin A-4 phosphate prodrug mono- and di-organic amine salts, mono- and di- amino acid salts, and mono- and di-amino acid ester salts
US20050153939A1 (en) * 2003-09-10 2005-07-14 Bristol-Myers Squibb Company Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts
WO2017031157A1 (en) 2015-08-18 2017-02-23 Mateon Therapeutics, Inc. Use of vdas to enhance immunomodulating therapies against tumors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4326055A (en) * 1977-12-22 1982-04-20 Hoffmann-La Roche Inc. Stilbene derivatives
DK159967C (da) * 1977-12-22 1991-06-03 Hoffmann La Roche Analogifremgangsmaade til fremstilling af terapeutisk aktive stilbenderivater
DE3202118A1 (de) * 1982-01-23 1983-07-28 Basf Ag, 6700 Ludwigshafen Substituierte vinylbenzoesaeure-derivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
DE3202100A1 (de) * 1982-01-23 1983-08-04 Basf Ag, 6700 Ludwigshafen Substituierte benzoesaeure-4-hydroxyanilide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen

Also Published As

Publication number Publication date
EP0176050B1 (de) 1989-01-25
EP0176050A3 (en) 1986-10-08
HUT40449A (en) 1986-12-28
NO853697L (no) 1986-03-24
HU193818B (en) 1987-12-28
AU4783785A (en) 1986-03-27
IL76455A (en) 1989-01-31
DE3567873D1 (en) 1989-03-02
AU573389B2 (en) 1988-06-09
IL76455A0 (en) 1986-01-31
EP0176050A2 (de) 1986-04-02
DE3438386A1 (de) 1986-04-03
CA1339138C (en) 1997-07-29
FI80044C (sv) 1990-04-10
FI853623A0 (fi) 1985-09-20
US4659701A (en) 1987-04-21
FI853623L (fi) 1986-03-23

Similar Documents

Publication Publication Date Title
FI88025C (sv) Förfarande för framställning av terapeutiskt aktiva vinylfenolderivat
US4806558A (en) Diarylacetylenes and their use in treating acne
US4760174A (en) Tetralin derivatives, their preparation and their use
EP0235796B1 (en) Dibenz [b,e] oxepin derivative and antiallergic and antiinflammatory agent
US4551475A (en) Pharmaceutical preparations for topical application which contain salts of alkanecarboxylic acids
IE55485B1 (en) Triphenylimidazolyloxyalkanoic acids and their derivatives,processes for their preparation and pharmaceutical preparations containing these compounds
HU193343B (en) Process for production of derivatives izoxalols
FI80044B (fi) Fosforsyravinylbenzylestrar, deras framstaellning och anvaendning.
EP0503582B1 (en) Glycyrrhetic acid derivatives
KR0171570B1 (ko) N-헤테로사이클릭프로필리덴-1,1-비스포스폰산,이의제조방법및약제학적조성물
US5244917A (en) Substituted naphthofurans as anti-inflammatory agents
US4421927A (en) New cinnamoyl-cinnamic acid derivative, and its use as pharmaceutical
US4539326A (en) 5-Oxo-5H-(1)benzopyrano(2,3-b)pyridine derivatives, their production and use as anti-inflammatory agents
WO1989003682A1 (en) Benzothiazine dioxide derivatives
US6903080B2 (en) Disease treatment with novel phospholipid derivatives
US5256694A (en) Diarylacetylenes, their preparation and their use
NZ191346A (en) Furyl substituted polyenes intermediates and pharmaceutical compositions
RU2090559C1 (ru) Рацемические или оптически активные производные изохинолина, способ их получения, фармацевтическая композиция на их основе и способ получения фармацевтической композиции
JPH0557277B1 (sv)
US4166125A (en) 2-oxo-phenylbutanoic acid derivatives
EP3967683A1 (en) Substituted fluorine-containing imidazole salt compound, preparation method therefor, pharmaceutical composition thereof and use thereof
JPS6185395A (ja) 燐酸ビニルベンジルエステル及びその製法
NO792590L (no) Alfa-aminofenyleddiksyrederivater.
EP0158170B1 (en) Erythromycin a salt with mucosecretolytic and fluidizing activity, a process for its preparation and pharmaceutical compositions thereof
US5574170A (en) Ketorolac derivatives with considerably reduced gastro-intestinal irritation and ulceration

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: BASF AKTIENGESELLSCHAFT